Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 3 - You Need To See This

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.

Benzinga

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories (NYSE:ABT) will release earnings results for the second quarter, before the opening bell on Thursday, July 17.

Benzinga

Forget Chasing Yields: These 3 Dividend Stocks Are Built to Last

Three top dividend growth stocks have strong fundamentals, analyst buy ratings, and decades of increases, found using Barchart’s free tool.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Overlooked Dividend Aristocrats To Buy in 2025

These three dividend companies all share one common trait: strong earnings growth and rising cash flow.

Barchart

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

Barchart

What to Expect From Abbott Laboratories' Q2 2025 Earnings Report

Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth.

Barchart

3 Under-The-Radar Dividend Aristocrats Set to Breakout in Q3

These three dividend companies all share one commonality: near-perfect buy ratings and breakout potential.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Dirt-Cheap Dividend Aristocrats About to Explode Higher

These buy-rated Dividend Aristocrats are trading at rare discounts, offering strong yields, bullish ratings, and potential long-term upside.

Barchart

3 Dividend Growth Stocks To Buy and Hold Forever

These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.

Barchart

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

Discover 3 Dividend Aristocrats with high earnings growth, low payout ratios, and strong analyst ratings: perfect for long-term income investors.

Barchart

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

The 3 Most Powerful Dividend Kings You’ve Probably Overlooked

These three Dividend Kings have strong cash flow and EPS growth, making a compelling case for long-term income investors.

Barchart

3 Dividend Aristocrats Quietly Dominating The Market in 2025

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

Barchart

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

These three Dividend Kings are beating the market in 2025, offering strong yields, reliable growth, and solid analyst buy ratings.

MarketBeat

Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.

Barchart

Stocks Extend Losses on Cautious Powell Remarks

The S&P 500 Index ($SPX ) (SPY ) today is down -2.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -3.29%. June E-mini S&P futures (ESM25 ) are down -2.16%, and June E-mini Nasdaq futures...

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Barchart

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Abbott Laboratories Stock?

Abbott Laboratories has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

StockNews.com

3 Healthcare Stocks Addressing Aging Population Needs

The healthcare industry is poised for growth driven by aging populations, technological advancements, and increased healthcare spending. Hence, investors might consider investing in healthcare stocks, such as UnitedHealth Group (UNH), Abbott Laboratories (ABT), and Medtronic (MDT), which address the needs of the aging population. Read more….

StockNews.com

3 Healthcare IT Stocks Driving Digital Transformation

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and promoting personalized care, making it a promising investment sector. Therefore, strong healthcare IT stocks like Medtronic (MDT), Abbott Laboratories (ABT), and Embecta (EMBC) could be wise additions to your portfolio. Read more.

MarketBeat

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Barchart

How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.